6 min listen
Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 27)
Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 27)
ratings:
Length:
10 minutes
Released:
Jun 29, 2022
Format:
Podcast episode
Description
In this week’s View, Dr. Eagle discusses the newly published table that lists drug-drug interactions with the anti-viral agent Paxlovid, used in treating COVID-19, then looks at an analysis of the LIFE Trial Run-In that examines the tolerability of sacubitril/valsartan in patients with advanced heart failure. Finally, Dr. Eagle explores the CABANA randomized clinical trial and its insights into the cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation.
Released:
Jun 29, 2022
Format:
Podcast episode
Titles in the series (94)
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of October 11): This week’s View focuses on hypertension treatment intensification in older adults, key points on physical activity and exercise in patients with spontaneous coronary artery dissection and fibromuscular dysplasia, and CV disease risk among cigarette... by Eagle's Eye View: Your Weekly CV Update From ACC.org